Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases

Journal of Surgical Oncology

Volumn 110, Issue 6, 2014, Pages 734-738

  Eltawil, Karim M ^a   Boame, Nana ^b   Mimeault, Richard ^a   Shabanafady, Wael ^b   Balaa, Fady K ^a   Jonker, Derek J ^b   Asmis, Tim R ^b   Martel, Guillaume ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Colorectal cancer; Liver resection; Metastasis; Radiofrequency ablation; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA; CATHETER ABLATION; COLORECTAL TUMOR; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PEROPERATIVE CARE; SECONDARY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 84912034999     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23689     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Steele G Jr, Ravikumar TS: Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989;210:127-138.
3. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-825.
4. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318.
5. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
6. Scheele J, Stang R, Altendorf-Hofmann A, et al.: Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
7. Bismuth H, Adam R, Levi F, et al.: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-520.
8. Minami Y, Kudo M: Radiofrequency ablation of liver metastases from colorectal cancer: A literature review. Gut Liver 2013;7:1-6.
9. Gold JS, Are C, Kornprat P, et al.: Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: Trends in treatment over time in 440 patients. Ann Surg 2008;247:109-117.
10. Rocha FG, D'Angelica M: Treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol 2010;102:968-974.
11. Shibata T, Niinobu T, Ogata N, et al.: Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000;89:276-284.
12. Otto G, Duber C, Hoppe-Lotichius M: Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg 2010;251:796-803.
13. White RR, Avital I, Sofocleous CT, et al.: Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastro-intest Surg 2007;11:256-263.
14. Gillams AR, Lees WR: Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005;30:419-426.
15. Livraghi T, Solbiati L, Meloni F: Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The "test-of-time approach". Cancer 2003;97:3027-3035.
16. Solbiati L, Livraghi T, Goldberg SN, et al.: Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001;221:159-166.
17. Wu YZ, Li B, Wang T, et al.: Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011;17:4143-4148.
18. Kuvshinoff BW, Ota DM: Radiofrequency ablation of liver tumors: Influence of technique and tumor size. Surgery 2002; 132:605-611.
19. Hildebrand P, Kleemann M, Roblick UJ: Radiofrequency-ablation of unresectable primary and secondary liver tumors: Results in 88 patients. Langenbecks Arch Surg 2006;391:118-123.
20. Cai GX, Cai SJ: Multi-modality treatment of colorectal liver metastases. World J Gastroenterol 2012;18:16-24.
21. Kingham TP, Tanoue M, Eaton A, et al.: Patterns of recurrence after ablation of colorectal cancer liver metastases. Ann Surg Oncol 2012;19:834-841.
22. Wong SL, Mangu PB, Choti MA, et al.: American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28:493-508.